↓ Skip to main content

PLOS

Multi-Target Drugs: The Trend of Drug Research and Development

Overview of attention for article published in PLOS ONE, June 2012
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
1 X user

Readers on

mendeley
288 Mendeley
citeulike
2 CiteULike
Title
Multi-Target Drugs: The Trend of Drug Research and Development
Published in
PLOS ONE, June 2012
DOI 10.1371/journal.pone.0040262
Pubmed ID
Authors

Jin-Jian Lu, Wei Pan, Yuan-Jia Hu, Yi-Tao Wang

Abstract

Summarizing the status of drugs in the market and examining the trend of drug research and development is important in drug discovery. In this study, we compared the drug targets and the market sales of the new molecular entities approved by the U.S. Food and Drug Administration from January 2000 to December 2009. Two networks, namely, the target-target and drug-drug networks, have been set up using the network analysis tools. The multi-target drugs have much more potential, as shown by the network visualization and the market trends. We discussed the possible reasons and proposed the rational strategies for drug research and development in the future.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 288 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 3 1%
United States 3 1%
Spain 3 1%
Indonesia 1 <1%
Pakistan 1 <1%
Hungary 1 <1%
Italy 1 <1%
Austria 1 <1%
Brazil 1 <1%
Other 5 2%
Unknown 268 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 74 26%
Student > Master 39 14%
Student > Bachelor 38 13%
Researcher 31 11%
Student > Postgraduate 18 6%
Other 49 17%
Unknown 39 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 66 23%
Chemistry 57 20%
Biochemistry, Genetics and Molecular Biology 30 10%
Pharmacology, Toxicology and Pharmaceutical Science 28 10%
Medicine and Dentistry 23 8%
Other 28 10%
Unknown 56 19%